David Feigenblum, MD
Clinical Cardiac Electrophysiology · Englewood, NJNPI 1356357420
Payments from drug & device makers
What this record shows
23 manufacturers reported payments, led by Medtronic at 36.7% of the total. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in NJ, where the typical reported total is $15,131.
Across 170 payments — averaging $64.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Abbott$4K
- Boston Scientific$1K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$324
- Cardiva Medical, Inc.$245
- Atricure, Inc.$244
- plus $930 from 17 others
Across 2 payments — averaging $4890.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$10K
What the payments were for
- Travel & lodging$4,37440%
- Food & beverage$6,55860%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 39 | $4,009 |
| Abbott | 42 | $3,936 |
| Boston Scientific | 21 | $1,245 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 15 | $324 |
| Cardiva Medical, Inc. | 5 | $245 |
| Atricure, Inc. | 5 | $244 |
| Biosense Webster, Inc. | 6 | $165 |
| Impulse Dynamics (USA) Inc. | 2 | $159 |
| Philips North America LLC | 3 | $141 |
| Cordis US CORP. | 6 | $98 |
| E.r. Squibb & Sons, L.L.C. | 5 | $67 |
| Novartis | 3 | $44 |
| Abiomed | 2 | $43 |
| Chiesi USA, Inc. | 3 | $39 |
| Pfizer | 3 | $38 |
| Portola Pharmaceuticals, LLC | 2 | $28 |
| Regeneron Healthcare Solutions, Inc. | 2 | $24 |
| Cardiovascular Systems Inc. | 1 | $15 |
| AstraZeneca | 1 | $15 |
| Johnson & Johnson | 1 | $15 |
| Amgen | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $12 |
| GSK | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$3,180
- EVERA MRI XT DR SURESCAN$1,034
- Reveal LINQ$485
- Arctic Front$318
- AURORA EV-ICD MRI SURESCAN$300
- OPTIMIZER$233
- CareLink$200
- Micra$190
- Cardiva VASCADE MVP VVCS 6-12F$162
- EMBLEM MRI S-ICD$157
- RESONATE EL ICD VR$146
- AZURE XT DR MRI SURESCAN$127
- GENERAL - THERAPIES$124
- Watchman$114
- MyCareLink$102
How this compares
$10,932 in reported general payments places this provider in the 35th percentile of 102 clinical cardiac electrophysiology providers in New Jersey.
See all clinical cardiac electrophysiology providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 78 | $51,690 |
| XareltoRivaroxaban | 16 | $14,284 |
| Dofetilide | 42 | $4,186 |
| Mexiletine Hcl | 17 | $1,942 |
| Amiodarone Hcl | 73 | $1,603 |
| Metoprolol Succinate | 44 | $619 |
| SotalolSotalol Hcl | 30 | $586 |
| Metoprolol Tartrate | 12 | $86 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $38 | $51,69078 claims |
| Johnson & JohnsonXarelto | $15 | $14,28416 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 102 clinical cardiac electrophysiology providers in New Jersey.
Other clinical cardiac electrophysiology in Englewood
- Grant SimonsEnglewood$93K
- Dmitry NemirovskyEnglewood$37K
- Benjamin D SouzaCherry Hill$741K
- Suneet MittalParamus$722K
- George MarkHaddon Heights$312K
- Raffaele CorbisieroBrowns Mills$135K
- Emad AzizNewark$112K
- Marc RoelkeWest Orange$110K
- Arjun TheerthamParlin$102K
- Michael LinkGalloway$96K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.